Drug Enforcement Administration April 2017 – Federal Register Recent Federal Regulation Documents

David D. Moon, D.O.; Decision and Order
Document Number: 2017-08452
Type: Notice
Date: 2017-04-27
Agency: Drug Enforcement Administration, Department of Justice
Robert Clark Maiocco, M.D.; Decision and Order
Document Number: 2017-08450
Type: Notice
Date: 2017-04-27
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Document Number: 2017-08347
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cambridge Isotope Laboratories
Document Number: 2017-08346
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Janssen Ortho LLC
Document Number: 2017-08345
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2017-08344
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals
Document Number: 2017-08343
Type: Notice
Date: 2017-04-25
Agency: Drug Enforcement Administration, Department of Justice
William H. Wyttenbach, M.D.; Decision and Order
Document Number: 2017-08013
Type: Notice
Date: 2017-04-21
Agency: Drug Enforcement Administration, Department of Justice
Richard Jay Blackburn, D.O.; Decision and Order
Document Number: 2017-08014
Type: Notice
Date: 2017-04-20
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I
Document Number: 2017-07118
Type: Rule
Date: 2017-04-10
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule six synthetic cannabinoids: methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate [5F-ADB; 5F-MDMB-PINACA]; methyl 2-(1-(5- fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate [5F-AMB]; N- (adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide [5F- APINACA, 5F-AKB48]; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA]; methyl 2-(1- (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutan oate [MDMB-CHMICA, MMB-CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-FUBINACA], and their optical, positional, and geometric isomers, salts, and salts of isomers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of these synthetic cannabinoids into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA or MDMB-FUBINACA.
Importer of Controlled Substances Application: Xcelience
Document Number: 2017-06555
Type: Notice
Date: 2017-04-04
Agency: Drug Enforcement Administration, Department of Justice